Robert J. MacFadyen

6.2k total citations · 1 hit paper
88 papers, 2.8k citations indexed

About

Robert J. MacFadyen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Cancer Research. According to data from OpenAlex, Robert J. MacFadyen has authored 88 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 15 papers in Cancer Research. Recurrent topics in Robert J. MacFadyen's work include Heart Failure Treatment and Management (21 papers), Protease and Inhibitor Mechanisms (15 papers) and Blood Pressure and Hypertension Studies (13 papers). Robert J. MacFadyen is often cited by papers focused on Heart Failure Treatment and Management (21 papers), Protease and Inhibitor Mechanisms (15 papers) and Blood Pressure and Hypertension Studies (13 papers). Robert J. MacFadyen collaborates with scholars based in United Kingdom, France and United States. Robert J. MacFadyen's co-authors include Gregory Y.H. Lip, Muzahir H. Tayebjee, Allan D. Struthers, Sunil Nadar, G Y H Lip, Hoong Sern Lim, Stuart D. Pringle, Andrew D. Blann, Ali Hamaad and Chung‐Kang Peng and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Robert J. MacFadyen

86 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society

2015 520 citations Gregory Y.H. Lip, Robert J. MacFadyen et al. profile →

Peers

Countries citing papers authored by Robert J. MacFadyen

Since Specialization

Citations

This map shows the geographic impact of Robert J. MacFadyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. MacFadyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. MacFadyen more than expected).

Fields of papers citing papers by Robert J. MacFadyen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. MacFadyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. MacFadyen. The network helps show where Robert J. MacFadyen may publish in the future.

Co-authorship network of co-authors of Robert J. MacFadyen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. MacFadyen. A scholar is included among the top collaborators of Robert J. MacFadyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. MacFadyen. Robert J. MacFadyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Markers of Thrombosis and Hemostasis in Acute Coronary Syndromes: Relationship to Increased Heart Rate and Reduced Heart‐Rate Variability 2009 ·Clinical Cardiology ·Ali Hamaad, Michael Sosin, Andrew D. Blann, Gregory Y.H. Lip, Robert J. MacFadyen	9
2	Neurohumoral Effects of the New Orally Active Renin Inhibitor, Aliskiren, in Chronic Heart Failure 2007 ·European Journal of Heart Failure ·Alison Seed, Roy S. Gardner, John J.V. McMurray, Chris Hillier, David Murdoch, Robert J. MacFadyen, (unknown), Jessica Mann, Theresa A. McDonagh	48
3	Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine? 2007 ·Current Opinion in Pharmacology ·Robert J. MacFadyen	14
4	Multiple microvessels extending from the coronary arteries to the left ventricle in a middle aged female presenting with ischaemic chest pain: a case report 2007 ·Journal of Medical Case Reports ·Robert J. MacFadyen, Chetan Varma, Robert H. Anderson	0
5	Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: Differences in central versus peripheral levels 2007 ·Annals of Medicine ·Rumi Jaumdally, Chetan Varma, Andrew D. Blann, Robert J. MacFadyen, Gregory Y.H. Lip	7
6	Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease 2007 ·Journal of Thrombosis and Thrombolysis ·Rumi Jaumdally, Chetan Varma, Robert J. MacFadyen, Gregory Y.H. Lip	3
7	The Role of Hyperglycaemia and the Hypercoagulable State in the Pathogenesis of Cardiovascular Events in Diabetes Mellitus: Implications for Hypertension Management 2006 ·Current Pharmaceutical Design ·Hoong Sern Lim, Robert J. MacFadyen, (unknown), Gregory Y.H. Lip	5
8	Relation of Platelet Activation to Coronary Angiographic Severity and Collateralization 2005 ·The American Journal of Cardiology ·Kiat Tsong Tan, Muzahir H. Tayebjee, Robert J. MacFadyen, Gregory Y.H. Lip	6
9	Short-Term Adjuvant Atorvastatin Improves Frequency Domain Indices of Heart Rate Variability in Stable Systolic Heart Failure 2005 ·Cardiovascular Drugs and Therapy ·Ali Hamaad, (unknown), Gregory Y.H. Lip, Robert J. MacFadyen	30
10	Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension 2005 ·American Journal of Hypertension ·Muzahir H. Tayebjee, Ioannis Karalis, Sunil Nadar, DG Beevers, Robert J. MacFadyen, G Y H Lip	44
11	Tissue inhibitor of metalloproteinse‐1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension 2005 ·European Journal of Clinical Investigation ·(unknown), Hoong Sern Lim, Sunil Nadar, Robert J. MacFadyen, G. Y. H. Lip	23
12	Markers of inflammation in acute coronary syndromes: Association with increased heart rate and reductions in heart rate variability 2005 ·Clinical Cardiology ·Ali Hamaad, Michael Sosin, Andrew D. Blann, Jeetesh V. Patel, Gregory Y.H. Lip, Robert J. MacFadyen	36
13	Ambulatory Blood Pressure Monitoring in Heart Failure: A Systematic Review 2004 ·European Journal of Heart Failure ·(unknown), Robert J. MacFadyen, R. Douglas Watson, Gregory Y.H. Lip	21
14	Acute Coronary Syndromes Presenting Solely with Heart Failure Symptoms: Are they Under Recognised? 2004 ·European Journal of Heart Failure ·Ali Hamaad, Gregory Y.H. Lip, Robert J. MacFadyen	2
15	1145-119 Tissue inhibitor of matrix metalloproteinase-1 is a marker of left ventricular diastolic dysfunction in diabetic heart disease 2004 ·Journal of the American College of Cardiology ·(unknown), Muzahir H. Tayebjee, Robert J. MacFadyen, Gregory Lip	2
16	2004 ·American Journal of Hypertension ·Muzahir H. Tayebjee, Sunil Nadar, A BLANN, (unknown), Robert J. MacFadyen, G Y H Lip	112
17	Unheralded sudden cardiac death: do autonomic tone and thrombosis interact as key factors in aetiology? 2003 ·Annals of Medicine ·Ali Hamaad, Gregory Y.H. Lip, Robert J. MacFadyen	7
18	Responses to an Orally Active Renin Inhibitor, Remikiren (Ro 42–5892), After Controlled Salt Depletion in Humans 1995 ·Journal of Cardiovascular Pharmacology ·Robert J. MacFadyen, Christopher Jones, (unknown), Herbert Birnböck, John L. Reid	17
19	Angiotensin-converting enzyme inhibitors in heart failure: Blood pressure changes after the first dose 1993 ·American Heart Journal ·(unknown), Robert J. MacFadyen, (unknown), K. R. Lees	26
20	Differential effects of ACE inhibiting drugs: Evidence for concentration-, dose-, and agent-dependent responses 1993 ·Clinical Pharmacology & Therapeutics ·Robert J. MacFadyen, Peter Meredith, Henry L. Elliott	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact